ArticleNature communications2020

Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting.

Christos Kontos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.